Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-390
Closed -$22.9K 623
2024
Q4
$22.9K Sell
390
-3,631
-90% -$215K ﹤0.01% 599
2024
Q3
$278K Buy
4,021
+342
+9% +$22.1K 0.01% 508
2024
Q2
$235K Buy
3,679
+152
+4% +$11.4K ﹤0.01% 525
2024
Q1
$331K Sell
3,527
-836
-19% -$67.3K 0.01% 541
2023
Q4
$321K Hold
4,363
0.01% 549
2023
Q3
$272K Buy
4,363
+1,240
+40% +$83.4K ﹤0.01% 573
2023
Q2
$231K Buy
3,123
+1,446
+86% +$110K ﹤0.01% 584
2023
Q1
$132K Sell
1,677
-288
-15% -$20.8K ﹤0.01% 551
2022
Q4
$134K Hold
1,965
﹤0.01% 525
2022
Q3
$104K Buy
+1,965
New +$117K ﹤0.01% 557

Other funds holding BRKR

Ossiam's BRKR Position: Q1 2025 in Review

Ossiam sold out of Bruker (BRKR) in Q1 2025, closing a stake of 390 shares — an estimated $22.9K sold.

Ossiam first reported a position in BRKR in Q3 2022 and held it in 10 quarters. The position peaked at $331K in Q1 2024. 399 funds tracked by Wall St. Rank hold BRKR as of Q1 2025.

  • Ossiam reported no remaining Bruker position as of Q1 2025 after selling out during the quarter.
  • Ossiam sold 390 Bruker shares in Q1 2025, an estimated $22.9K.
  • Ossiam first reported a position in Bruker in Q3 2022 and held it in 10 quarters.
  • Ossiam's Bruker position peaked at $331K in Q1 2024.
  • 399 funds tracked by Wall St. Rank held Bruker as of Q1 2025.

Based on Ossiam's 13F filing for Q1 2025, filed 14 May 2025.